Discuss the significance of NITI Aayog's 'Strategic Roadmap for Making Ayurveda Global' in advancing India's soft power and export economy.

Q. Discuss the significance of NITI Aayog's 'Strategic Roadmap for Making Ayurveda Global' in advancing India's soft power and export economy. (15 marks, 250-350 words)

Released on 2 July 2026 by NITI Aayog's Health Division, the 'Strategic Roadmap for Making Ayurveda Global' is the first dedicated policy blueprint to convert a civilisational knowledge system into a globally recognised healthcare and export sector by 2047 [1]. Its significance lies in treating Ayurveda simultaneously as a trade asset and a diplomatic instrument.

Significance for the export economy - It builds on demonstrated momentum: Ayurvedic products already reach nearly 150 countries, with exports rising from USD 1.09 billion in 2014 to USD 2.16 billion in 2023 [2]. - The three-pillar framework — Availability, Acceptability, Propagation — targets manufacturing scale, international R&D, regulatory compliance and insurance coverage, which are the real non-tariff barriers to traditional medicine trade [2]. - Standardised global education and workforce mobility address a structural gap: of over 3.55 lakh trained practitioners, about 95% remain within India [2], limiting services exports. - Medical value travel is mainstreamed as an export channel, linking wellness tourism to employment and value creation [1].

Significance for soft power - The Propagation pillar pursues strategic brand positioning, global visibility and representation in international bodies, converting cultural heritage into institutional influence [2]. - The Ministry of External Affairs is a co-stakeholder alongside the Ministry of Ayush and NITI Aayog, signalling a shift from single-ministry promotion to a whole-of-government health diplomacy approach [3]. - Localisation and cultural adaptability are explicitly built in, avoiding the credibility loss that unadapted export of traditional systems invites [2]. - Alignment with Viksit Bharat@2047 ties Ayurveda to India's larger developmental narrative [1].

Challenges persist — divergent foreign classification of Ayurvedic products as drugs or supplements, limited mutual recognition of practitioners, and a thin peer-reviewed evidence base.

The roadmap's real value is that it reframes globalisation of Ayurveda as a governance and standards problem rather than a promotional one. If matched with rigorous clinical validation, regulatory harmonisation through bilateral agreements, and quality assurance in manufacturing, it can make Ayurveda a credible pillar of India's export basket and its knowledge-based soft power by 2047.

(~330 words)

Sources: 1. NITI Aayog launches report on "Strategic Roadmap for Making Ayurveda Global" — PIB, 2 July 2026 — launch date, lead body, medical value travel, Viksit Bharat@2047 alignment 2. Strategic Roadmap for Making Ayurveda Global — NITI Aayog — export figures, 150 countries, three-pillar framework, practitioner numbers, education and localisation 3. Release of the report "Strategic Roadmap for Making Ayurveda Global" — Media Invitation, PIB — inter-ministerial participation at launch